Cetera Advisors LLC Organon & Co. Transaction History

Cetera Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.78 - $18.8 $236,230 - $322,288	17,143 New	17,143 $322,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $15,861 - $19,488	-501 Reduced 6.24%	7,525 $254,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $10,779 - $13,933	-354 Reduced 4.22%	8,026 $280,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $40,338 - $52,241	-1,407 Reduced 14.38%	8,380 $255,000
Q3 2021 Nov 16, 2021	BUY	$28.63 - $35.64 $33,268 - $41,413	1,162 Added 13.47%	9,787 $321,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $245,381 - $327,750	8,625 New	8,625 $261,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.